{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:55:50Z","timestamp":1762430150950},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/ncpuro0754","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T13:50:28Z","timestamp":1175781028000},"page":"174-175","source":"Crossref","is-referenced-by-count":15,"title":["Defining the role of overactive bladder treatments in men with lower urinary tract symptoms"],"prefix":"10.1038","volume":"4","author":[{"given":"Gary E","family":"Lemack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpuro0754_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/nau.10057","volume":"21","author":"R Machino","year":"2002","unstructured":"Machino R  et al. (2002) Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy. Neurourol Urodyn 21: 444\u2013449","journal-title":"Neurourol Urodyn"},{"key":"BFncpuro0754_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S0022-5347(17)56918-9","volume":"121","author":"PH Abrams","year":"1979","unstructured":"Abrams PH  et al. (1979) The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 121: 640\u2013642","journal-title":"J Urol"},{"key":"BFncpuro0754_CR3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","volume":"175","author":"P Abrams","year":"2006","unstructured":"Abrams P  et al. (2006) Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J Urol 175: 999\u20131004","journal-title":"J Urol"},{"key":"BFncpuro0754_CR4","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","volume":"174","author":"SA Kaplan","year":"2005","unstructured":"Kaplan SA  et al. (2005) Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol 174: 2273\u20132275","journal-title":"J Urol"},{"key":"BFncpuro0754_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","volume":"48","author":"C Chapple","year":"2005","unstructured":"Chapple C  et al. (2005) The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48: 5\u201326","journal-title":"Eur Urol"},{"key":"BFncpuro0754_CR6","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","volume":"169","author":"A Athanasopoulos","year":"2003","unstructured":"Athanasopoulos A  et al. (2003) Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J Urol 169: 2253\u20132256","journal-title":"J Urol"},{"key":"BFncpuro0754_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","volume":"94","author":"JY Lee","year":"2004","unstructured":"Lee JY  et al. (2004) Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int 94: 817\u2013820","journal-title":"BJU Int"},{"key":"BFncpuro0754_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1464-410X.2006.06068.x","volume":"97","author":"CG Roehrborn","year":"2006","unstructured":"Roehrborn CG  et al. (2006) Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int 97: 1003\u20131006","journal-title":"BJU Int"},{"key":"BFncpuro0754_CR9","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","volume":"296","author":"SA Kaplan","year":"2006","unstructured":"Kaplan SA  et al. (2006) Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA 296: 2319\u20132328","journal-title":"JAMA"}],"container-title":["Nature Clinical Practice Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0754","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpuro0754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:14:30Z","timestamp":1684440870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpuro0754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BFncpuro0754"],"URL":"https:\/\/doi.org\/10.1038\/ncpuro0754","relation":{},"ISSN":["1743-4270","1743-4289"],"issn-type":[{"value":"1743-4270","type":"print"},{"value":"1743-4289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}